Alan K. Tse, Chief Legal Officer of Jones Lang LaSalle Inc, filed a Form 4 on August 18, 2026, reporting transactions in common stock and restricted stock units that occurred on August 15, 2026.
A Form 4 filed with the SEC on August 18, 2026, disclosed that David M. Sparby, a director of Everus Construction Group, Inc. (NYSE:ECG), purchased 1,000 shares of common stock on August 17, 2026.
Joshua M. Nash, Executive Vice President at Camden National Corp, filed a Form 4 on August 18, 2026, disclosing three equity award acquisitions transacted on August 14, 2026, under the company's 2022 Equity and Incentive Plan and Amendment.
A Form 4 filed on August 18, 2026, reports that Brandon Y. Boey, an Executive Vice President at Camden National Corp (NASDAQ:CAC), received three equity award grants on August 14, 2026, under the company's 2022 Equity and Incentive Plan and Amendment.
A Form 4 filed with the SEC on August 18, 2026 discloses that Pierre Rochard, a director of Strive, Inc. (NASDAQ:ASST), purchased 15,900 shares of Class A Common Stock in an open market transaction on August 14, 2026.
Andrew John Bart, Executive Vice President of Crawford & Company, filed a Form 4 on August 18, 2026, disclosing two open-market sales of Class A Common Stock executed on August 14 and August 17, 2026.
A Statement of Changes in Beneficial Ownership was filed on August 18, 2026, disclosing that Wang Yan, a director of Weibo Corp, acquired 6,250 American depositary shares through the vesting of restricted shares on August 16, 2026.
Director Du Hong of Weibo Corp filed a Form 4 on August 18, 2026, disclosing two transactions in American depositary shares on August 16 and August 17, 2026, stemming from the vesting of restricted shares.
Shan Yigang, an Executive Director of KE Holdings Inc., filed a statement of changes in beneficial ownership with the U.S. Securities and Exchange Commission on August 18, 2026, reporting a conversion of Class B ordinary shares into Class A ordinary shares that occurred on …
A Form 4 filed with the SEC on August 18, 2026, discloses that Kerrii B. Anderson, a director of Labcorp Holdings Inc. (NYSE:LH), sold 3,000 shares of common stock on August 17, 2026, pursuant to a pre-established Rule 10b5-1 trading plan.